Theralase Technologies Inc.
TLTFF
$0.14
$0.002.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.81% | -50.85% | 33.06% | -6.77% | 32.87% |
| Total Depreciation and Amortization | -15.96% | -18.39% | 8.52% | 8.09% | -1.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.33% | 91.96% | -65.91% | 1.14% | -6.97% |
| Change in Net Operating Assets | -145.06% | 191.48% | -859.03% | 129.66% | -135.68% |
| Cash from Operations | -392.72% | 80.04% | -76.57% | 32.19% | -199.31% |
| Capital Expenditure | -433.33% | -101.99% | 374.55% | -35.80% | 82.00% |
| Sale of Property, Plant, and Equipment | -21.43% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -362.50% | -97.35% | 374.55% | -35.80% | 82.00% |
| Total Debt Issued | -- | -- | 175.00% | -- | -- |
| Total Debt Repaid | -25.28% | -113.71% | 57.68% | 14.58% | -41.15% |
| Issuance of Common Stock | 406.30% | 6.40% | 53.44% | -31.67% | 221.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 405.04% | -17.15% | 72.67% | -21.55% | 249.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 407.67% | 707.66% | 190.08% | 140.78% | 35.29% |